Related Experiment Video
Updated: Aug 10, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
[Research progress in clinical diagnosis and treatment of osteosarcoma of the jaw]
1Department of Oral Mucosa, Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South University & Hunan Clinical Research Center of Oral Major Diseases and Oral Health,Changsha, 410008, China.
Abstract:
Osteosarcoma of the jaw (JOS), is a relatively rare type of osteosarcoma, with a unique pathogenesis and pathological manifestations. The clinical manifestation of JOS is not characteristic, and it often needs to be diagnosed by combining radiological and pathological examination. At present, the conventional treatment of JOS is a comprehensive treatment based on surgery and supplemented by radiotherapy and chemotherapy. Recently, the emergence of new therapies such as immunotherapy, gene therapy, phototherapy and traditional Chinese medicine has provided more choices for treatment and brought new hope to patients with JOS. Therefore, this article summarized the current understanding of diagnosis and the latest treatment development of JOS.

